CUX1 and neoplasm: Investigations on pancreatic neurosecretory tumors (pan-NET) have demonstrated that CUX1 serves as a prognostic marker post PanNET surgery and facilitates in vitro tumor progression through enhanced proliferation and angiogenesis [32].